Evidence-based choice of ritonavir as index CYP3A inhibitor in drug-drug interaction studies
- PMID: 26239522
- DOI: 10.1002/jcph.609
Evidence-based choice of ritonavir as index CYP3A inhibitor in drug-drug interaction studies
Comment on
-
Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.J Clin Pharmacol. 2016 Feb;56(2):143-51. doi: 10.1002/jcph.562. Epub 2015 Jul 29. J Clin Pharmacol. 2016. PMID: 26044116 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
